AlphaFold predicted structure
AMPD2 · Q01433

Mean pLDDT
80.7/ 100
Confident
825 residues
Confidence breakdown
- Very high(≥ 90)58%
- Confident(70–90)18%
- Low(50–70)8%
- Very low(< 50)16%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
adenosine monophosphate deaminase 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Ataxia and cerebellar anomalies - narrow panel
BIALLELIC, autosomal or pseudoautosomalCerebellar hypoplasia
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalHereditary ataxia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalAdult onset hereditary spastic paraplegia
BIALLELIC, autosomal or pseudoautosomal+6 more panels — install the extension to see the full list inline on any page.
pontocerebellar hypoplasia type 9
pontocerebellar hypoplasia
hereditary spastic paraplegia 63
Non-syndromic pontocerebellar hypoplasia
Autosomal recessive spastic paraplegia type 63
hereditary disease
Abnormality of the nervous system
spastic ataxia
Global developmental delay
cerebral malformation
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
AMP deaminase 2
AMP deaminase plays a critical role in energy metabolism. Catalyzes the deamination of AMP to IMP and plays an important role in the purine nucleotide cycle
AMPD2 · Q01433

Mean pLDDT
80.7/ 100
Confident
825 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0